Manuscripts from 2012
Neurophysiological Impact and Modeling-independent elucidation of inactivation pathways in A-type K+ channels, J.D. Fineberg, David Ritter, and Manuel Covarrubias
Manuscripts from 2010
Mechanism of catch force: tethering of thick and thin filaments by twitchin., Thomas M Butler and Marion J Siegman
Manuscripts from 2009
Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle., Maria Regina Freitas, Masumi Eto, Jason A Kirkbride, Christa Schott, Jean Sassard, and Jean-Claude Stoclet
Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation., Jee In Kim, Garbo D Young, Li Jin, Avril V Somlyo, and Masumi Eto
Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1., Shunsuke Mori, Ryou Iwaoka, Masumi Eto, and Shin-ya Ohki
Manuscripts from 2008
Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women, Edward R. Sauter, Wenyi Qin, John E. Hewett, Rachel L. Ruhlen, John T. Flynn, George Rottinghaus, and Yin-Chieh Chen
Manuscripts from 2007
Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions, Masumi Eto, Jason Kirkbride, Elizabeth Elliott, Su Hao Lo, and David L. Brautigan
Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor, Masumi Eto, Toshio Kitazawa, Fumiko Matsuzawa, Sei-ichi Aikawa, Jason A. Kirkbride, Noriyoshi Isozumi, Yumi Nishimura, David L. Brautigan, and Shin-ya Ohki
Manuscripts from 2006
Gαq and its Aktions, David M. Harris, Andrea D. Eckhart, and Walter J. Koch
Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer, Edward R. Sauter, Wenyi Quin, Lisa Schlatter, John E. Hewett, and John T. Flynn